Video Experimental Relacionado
Updated: Jun 3, 2026
05:51
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Resumen
El Programa de Enfermedades No Diagnosticadas de los Institutos Nacionales de Salud ha diagnosticado con éxito 39 enfermedades raras utilizando la secuenciación de exomas enteros. Esta iniciativa está avanzando genómica personal y técnicas de gestión de datos para la información genómica compleja.
Área de la Ciencia:
- La medicina genómica es la medicina genómica.
- Diagnóstico de enfermedades raras Diagnóstico de enfermedades raras
- Genómica Clínica La genómica clínica es la genómica clínica.
Sus antecedentes:
- El Programa de Enfermedades No Diagnosticadas (UDP) de los Institutos Nacionales de la Salud (NIH, por sus siglas en inglés) se estableció para abordar los desafíos de diagnóstico en enfermedades raras.
- Las tecnologías genómicas ofrecen potentes herramientas para diagnosticar afecciones que han permanecido elusivas a través de los métodos tradicionales.
Objetivo del estudio:
- Evaluar el impacto y el éxito de la implementación de la secuenciación de exomas a gran escala en un entorno clínico.
- Demostrar el rendimiento diagnóstico de la genómica para pacientes con enfermedades raras no diagnosticadas.
- Para resaltar los avances en la gestión e interpretación de grandes volúmenes de datos genómicos.
Principales métodos:
- Se realizó la secuenciación completa del exoma en una cohorte de pacientes con enfermedades no diagnosticadas.
- Se desarrollaron y aplicaron canalizaciones de análisis de datos genómicos para la identificación e interpretación de variantes.
- Se realizó una correlación clínica de las variantes genéticas identificadas para establecer diagnósticos.
Principales resultados:
- La secuenciación de 128 exomas condujo al diagnóstico de 39 enfermedades raras.
- El programa demostró una tasa significativa de éxito en el diagnóstico, mejorando los resultados de los pacientes.
- Se desarrollaron nuevos métodos para gestionar el "tsunami" de datos genómicos.
Conclusiones:
- La genómica clínica a gran escala, particularmente la secuenciación de exomas enteros, es efectiva para el diagnóstico de enfermedades raras.
- El éxito del UDP de los NIH proporciona un modelo para integrar la genómica en la práctica clínica de rutina.
- La innovación continua en el análisis y la gestión de datos genómicos es crucial para el futuro de la genómica personal.
Videos de Conceptos Relacionados
03:21RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:57Sanger Sequencing
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...